Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Soft Tissue Tumor and/or Sarcoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT00112645
What this trial is testing

Donor Stem Cell Transplant in Treating Young Patients With Relapsed or Refractory Solid Tumors

Who this might be right for
NeuroblastomaSarcomaUnspecified Childhood Solid Tumor, Protocol Specific
Milton S. Hershey Medical Center 10
Testing effectiveness (Phase 2)Study completedNCT00379145
What this trial is testing

Trabectedin in Treating Patients With Advanced, Persistent, or Recurrent Leiomyosarcoma of the Uterus

Who this might be right for
Sarcoma
Gynecologic Oncology Group 20
Testing effectiveness (Phase 2)Study completedNCT01303094
What this trial is testing

Continuing vs Intermittent Trabectedin in Patients With Advanced Soft Tissue Sarcoma

Who this might be right for
Soft Tissue SarcomaUterine Sarcoma
Centre Oscar Lambret 53
Testing effectiveness (Phase 2)Study completedNCT00051597
What this trial is testing

A Safety/Efficacy Study of SGN-30 (Antibody) in Patients With Refractory or Recurrent CD30+ Hematologic Malignancies

Who this might be right for
Hodgkin DiseaseLymphoma, Large-CellSarcoma, Kaposi+2 more
Seagen Inc. 70
Not applicableLooking for participantsNCT07141862
What this trial is testing

Fertility Preservation in Children With Solid Tumors: Detection of Residual Disease by a Sensitive Method

Who this might be right for
NeuroblastomaEwing Sarcoma
University Hospital, Clermont-Ferrand 89
Early research (Phase 1)Ended earlyNCT00004261
What this trial is testing

EF5 Prior to Surgery or Biopsy in Patients With Breast, Prostate, or Cervical Cancer or High Grade Soft Tissue Sarcoma

Who this might be right for
Breast CancerCervical CancerHead and Neck Cancer+2 more
University Health Network, Toronto
Early research (Phase 1)Study completedNCT01005797
What this trial is testing

Study of Panobinostat in Combination With Sorafenib in Kidney, Soft Tissue or Lung Cancers

Who this might be right for
Renal CancerNon Small Cell Lung Cancer (NSCLC)Soft Tissue Sarcoma
Medical University of South Carolina 38
Testing effectiveness (Phase 2)UnknownNCT03989596
What this trial is testing

Hypofractionated Radiotherapy With Hyperthermia in Unresectable or Marginally Resectable Soft Tissue Sarcomas

Who this might be right for
SarcomaAlveolar Soft Part SarcomaClear Cell Sarcoma+8 more
Maria Sklodowska-Curie National Research Institute of Oncology 30
Testing effectiveness (Phase 2)Active Not RecruitingNCT05440786
What this trial is testing

CAMPFIRE: A Study of Abemaciclib (LY2835219) in Participants With Ewing's Sarcoma

Who this might be right for
Sarcoma, EwingNeoplasm Metastasis
Eli Lilly and Company 46
Early research (Phase 1)WithdrawnNCT01130623
What this trial is testing

A Phase I Study of Pazopanib as a Single Agent for Children With Refractory Solid Tumors

Who this might be right for
SarcomaNeuroblastomaWilms Tumor+2 more
National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Looking for participantsNCT07516925
What this trial is testing

Ivonescimab in People With Leiomyosarcoma

Who this might be right for
Leiomyosarcoma
Memorial Sloan Kettering Cancer Center 20
Testing effectiveness (Phase 2)Study completedNCT00005862
What this trial is testing

SU5416 in Treating Patients With Advanced, Metastatic, or Recurrent Soft Tissue Sarcomas

Who this might be right for
Gastrointestinal Stromal TumorSarcoma
National Cancer Institute (NCI) 60
Early research (Phase 1)Study completedNCT00049023
What this trial is testing

Radiolabeled Octreotide in Treating Children With Advanced or Refractory Solid Tumors

Who this might be right for
Brain and Central Nervous System TumorsGastrointestinal Carcinoid TumorIslet Cell Tumor+4 more
O'Dorisio, M S 27
Testing effectiveness (Phase 2)Study completedNCT03245450
What this trial is testing

Study Evaluating the Safety and Efficacy of Eribulin Mesilate in Combination With Irinotecan Hydrochloride in Children With Refractory or Recurrent Solid Tumors

Who this might be right for
Refractory or Recurrent Solid TumorsRhabdomyosarcomaNon-Rhabdomyosarcoma Soft Tissue Sarcoma+1 more
Eisai Inc. 40
Testing effectiveness (Phase 2)Active Not RecruitingNCT04917042
What this trial is testing

Tazemetostat in Malignant Peripheral Nerve Sheath Tumors

Who this might be right for
Peripheral Nerve Sheath Tumor
University of Florida 10
Testing effectiveness (Phase 2)Study completedNCT01833520
What this trial is testing

Phase I Dose Escalation of Monthly Intravenous Ra-223 Dichloride in Osteosarcoma

Who this might be right for
Sarcoma
M.D. Anderson Cancer Center 18
Early research (Phase 1)Study completedNCT01522820
What this trial is testing

Vaccine Therapy With or Without Sirolimus in Treating Patients With NY-ESO-1 Expressing Solid Tumors

Who this might be right for
Anaplastic AstrocytomaAnaplastic OligoastrocytomaAnaplastic Oligodendroglioma+62 more
Roswell Park Cancer Institute 18
Not applicableApproved For MarketingNCT00481559
What this trial is testing

Treatment Protocol of Voraxaze for Patients Experiencing or at Risk of Methotrexate Toxicity

Who this might be right for
Neoplasms
BTG International Inc.
Testing effectiveness (Phase 2)Study completedNCT01330966
What this trial is testing

Study of Pazopanib in the Treatment of Surgically Unresectable or Metastatic Chondrosarcoma

Who this might be right for
ChondrosarcomaMetastatic Chondrosarcoma
Emerald Clinical Inc. 47
Testing effectiveness (Phase 2)Study completedNCT00227669
What this trial is testing

Gemcitabine With or Without Docetaxel as Second-Line Therapy in Treating Patients With Metastatic or Relapsed, Unresectable Uterine or Soft Tissue Leiomyosarcoma

Who this might be right for
Sarcoma
UNICANCER 90
Next Page